Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals 2021-01-28 22:03
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK 2021-01-28 15:30
Women's reproductive healthcare in Asia gets boost with first at-home blood-testing kit for female fertility 2021-01-28 10:16
CStone Pharmaceuticals Reports Efficacy and Safety Data from the ARROW Trial of Pralsetinib in Chinese Patients with Advanced RET Fusion-positive Non-Small Cell Lung Cancer after Platinum-based Chemotherapy at IASLC WCLC 2020 2021-01-28 10:15
Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease 2021-01-28 09:00
Transnetyx, One Codex Build Strategic Partnership to Provide a Complete Microbiome Analysis Service for Both Mice and Humans 2021-01-28 03:29
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer 2021-01-27 21:00
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study 2021-01-27 20:00
Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China 2021-01-26 23:45
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta 2021-01-26 21:23
Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales 2021-01-26 15:00
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine 2021-01-26 01:18
China Biologic Announces Extraordinary General Meeting of Shareholders 2021-01-25 21:44
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program 2021-01-25 21:00
KPMG announces Top 50 Biotech Enterprises in the Greater Bay Area 2021-01-25 16:35
Antengene Announces Approval of IND Application in China for ATG-010 (Selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study 2021-01-25 08:20
HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC) 2021-01-25 06:00
Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021 2021-01-22 21:00
Nanoform's Clinical Study Indicates Positive Interim Results 2021-01-22 15:43
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) 2021-01-22 02:25
1 260 261 262 263 264 451